Rising Obesity-Associated Mortality in Men: Exploration of Gender Disparity from the Global Burden of Disease Study, 1990-2019

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2024 Sep 20

PMID 39302563

Authors

Yichen Wang

Yuting Huang

Mhd Manar Al Jawish

Nader G Bakheet

Andres Acosta

Tamas Ordog

Kristin Clift

Katherine Chase

Vivek Kumbhari

Dilhana S Badurdeen

Affiliations

Soon will be listed here.

Abstract

Objectives: The global rise in overweight, obesity, and related diseases is undeniable; however, the pathogenesis of obesity and obesity-associated diseases is heterogeneous, with varied complications and a discordant response to treatment. Intriguingly, men have a shorter lifespan than women, despite being half as likely to be obese. This paradox suggests a potential gender disparity in the impact of obesity on mortality, with men potentially being more vulnerable to obesity-associated health risks.

Methods: This retrospective study utilized Global Burden of Diseases data from 204 countries/territories to bridge the knowledge gap in understanding gender disparities in obesity-related mortality. Outcomes were obesity-associated mortality, years of life lost, years lived with disability, and disability-adjusted life years (DALYs).

Results: In 2019, the global overweight/obesity-related disease burden reached 160.2 million DALYs, with 5.02 million associated deaths. From 1990 to 2019, the age-standardized death rates increased in males (from 58.19 to 66.55 per 100,000 person-years, APC = 0.36%, 95% CI: 0.30 to 0.42%, P < 0.001), while females experienced a decrease in age-standardized death rates (from 59.31 to 58.14 per 100,000 person-years, APC = -0.22%, 95% CI: -0.29% to -0.14%, P < 0.001). Age-standardized DALYs increased more in males (1632.5 to 2070.34 per 100,000 years, APC = 0.74%, 95% CI: 0.70% to 0.78%, P < .001) compared to females (1618.26 to 1789.67 per 100,000 years, APC = 0.24%, 95% CI: 0.19% to 0.29%, P < 0.001). Disparities were more pronounced in countries with a higher socioeconomic status and predominantly affected younger populations.

Conclusions: Overweight/obesity-related morbidity and mortality are higher among male sex. Identifying differences in pathogenesis, complications and treatment response is crucial to develop targeted interventions and equitable public health policies to combat this global burden.

Citing Articles

Isoliquiritigenin Ameliorates High-Fat Diet-Induced Obesity in Mice by Activating Brown Adipose Tissue.

Zhao L, Li M, Zhu Q, Fang X, Yang H, Zhao Y Int J Mol Sci. 2025; 26(4).

PMID: 40004080 PMC: 11855605. DOI: 10.3390/ijms26041616.

References

Swinburn B, Kraak V, Allender S, Atkins V, Baker P, Bogard J . The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet. 2019; 393(10173):791-846. DOI: 10.1016/S0140-6736(18)32822-8. View

Bianchettin R, Lavie C, Lopez-Jimenez F . Challenges in Cardiovascular Evaluation and Management of Obese Patients: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023; 81(5):490-504. DOI: 10.1016/j.jacc.2022.11.031. View

Kahn S, Hull R, Utzschneider K . Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121):840-6. DOI: 10.1038/nature05482. View

Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K . Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016; 375(8):794-8. PMC: 6754861. DOI: 10.1056/NEJMsr1606602. View

Guglielmo D, Hootman J, Murphy L, Boring M, Theis K, Belay B . Health Care Provider Counseling for Weight Loss Among Adults with Arthritis and Overweight or Obesity - United States, 2002-2014. MMWR Morb Mortal Wkly Rep. 2018; 67(17):485-490. PMC: 5933870. DOI: 10.15585/mmwr.mm6717a2. View

Withrow D, Alter D . The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2010; 12(2):131-41. DOI: 10.1111/j.1467-789X.2009.00712.x. View

Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C . Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945):766-81. PMC: 4624264. DOI: 10.1016/S0140-6736(14)60460-8. View

Mauvais-Jarvis F, Merz N, Barnes P, Brinton R, Carrero J, DeMeo D . Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020; 396(10250):565-582. PMC: 7440877. DOI: 10.1016/S0140-6736(20)31561-0. View

Kanter R, Caballero B . Global gender disparities in obesity: a review. Adv Nutr. 2012; 3(4):491-8. PMC: 3649717. DOI: 10.3945/an.112.002063. View

10.

Murray C, Lopez A . Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349(9063):1436-42. DOI: 10.1016/S0140-6736(96)07495-8. View

11.

Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

12.

Popkin B, Adair L, Ng S . Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012; 70(1):3-21. PMC: 3257829. DOI: 10.1111/j.1753-4887.2011.00456.x. View

13.

Jaacks L, Vandevijvere S, Pan A, McGowan C, Wallace C, Imamura F . The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019; 7(3):231-240. PMC: 7360432. DOI: 10.1016/S2213-8587(19)30026-9. View

14.

Pampel F, Denney J, Krueger P . Obesity, SES, and economic development: a test of the reversal hypothesis. Soc Sci Med. 2012; 74(7):1073-81. PMC: 3298576. DOI: 10.1016/j.socscimed.2011.12.028. View

15.

Must A, Tybor D . Physical activity and sedentary behavior: a review of longitudinal studies of weight and adiposity in youth. Int J Obes (Lond). 2005; 29 Suppl 2:S84-96. DOI: 10.1038/sj.ijo.0803064. View

16.

Nikolaou C, Robinson T, Sim K, Lean M . Turning the tables on obesity: young people, IT and social movements. Nat Rev Endocrinol. 2019; 16(2):117-122. DOI: 10.1038/s41574-019-0288-1. View

17.

Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

18.

Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Barnighausen T . The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017; 5(6):423-430. DOI: 10.1016/S2213-8587(17)30097-9. View

19.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B . Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888):260-72. DOI: 10.1016/S0140-6736(13)60687-X. View

20.

Mokdad A, Ford E, Bowman B, Dietz W, Vinicor F, Bales V . Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2002; 289(1):76-9. DOI: 10.1001/jama.289.1.76. View